News

03/12/2013 - 2012 Deloitte Technology Fast 500 EMEA Winner

In Europe, Graftys is the first in the Biotech/health industry and 28th in all sectors. See the news
See all news

Contact international Eiffel Park - Bâtiment D
415, rue Claude Nicolas Ledoux
Pôle d'Activités d'Aix en Provence
13 854 AIX EN PROVENCE Cedex 3
Office : +33(4) 42 60 30 00
Fax : +33(4) 42 60 30 11
France
Contactez nous

Contact USA NaviMed International LLC
US representation for Graftys SA
office: 847-573-1028
fax: 847-557-9089
Chicago, IL, USA
Contact US

In constant pursuit of excellence and innovation, Graftys is a leader in the development of bioactive bone substitutes. Created in 2005, Graftys researches and develops materials for a range of needs, including bone substitute materials, bone augmentation implants and spine fusion, among others. The company has products such as a calcium phosphate bone substitute and injectable bone substitute for synthetic bone graft and sinus lift procedures. For example, its innovative calcium phosphate bone substitute can be used for such procedures as bone grafting in revision surgery and as bone void filler.